Alia Therapeutics

Safe and durable gene editing solutions for patients

Trento, Italy · Founded 2018 · $7.0M raised

Headquarters
Trento
Employees
1–10
Founded
2018
Business Model
B2B
Total Funding
$7.0M
Last Round
$2.2M Extension RoundFeb 2021
Rounds
2

About

Alia Therapeutics is a biotechnology company dedicated to developing next-generation gene editing therapies for Inherited Retinal Diseases, starting with Retinitis Pigmentosa, a leading cause of inherited blindness worldwide. The company leverages a proprietary CRISPR platform featuring novel, next-generation enzymes discovered in-house that enable a modular, mutation-agnostic approach using a single AAV vector. Founded in 2018 out of pioneering research at Trento University, Alia aims to transform treatment of inherited blindness by delivering scalable, precise, and durable gene editing solutions.

Summary

Alia Therapeutics is a Biotech company based in Trento, Italy, founded in 2018. It has raised $7.0M in total across 2 rounds, most recently a $2.2M Extension Round round in Feb 2021. Investors include Sofinnova Partners, Bpifrance and Indaco Venture Partners.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundExtension RoundFeb 2021
$2.2M

Sign up to see all 2 rounds

Seed through Extension Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alia Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/alia-therapeutics"><img src="https://indexed.vc/api/badge/company/alia-therapeutics" alt="Alia Therapeutics on Indexed.vc" width="260" height="76" /></a>